File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Helicobacter pylori sero-prevalence in asthma

TitleHelicobacter pylori sero-prevalence in asthma
Authors
KeywordsAsthma
Helicobacter pylori
Inflammation
Sero-revalence
Issue Date2000
PublisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/rmed
Citation
Respiratory Medicine, 2000, v. 94 n. 8, p. 756-759 How to Cite?
AbstractAsthma is a very common respiratory disease which is characterized by the presence of cytokine-mediated airway inflammation leading to smooth muscle contraction, oedema and progressive airway damage in some cases. In light of our recent finding of an increased sero-prevalence of Helicobacter pylori in bronchiectasis, we have determined serum levels of H. pylori-specific IgG in asthmatic and control subjects. Altogether 90 consecutive asthmatic [mean age±SD 42·6±16 years and 52 female (F)] and 97 healthy control subjects (mean age ±SD 43·2 ± 13·3 years and 51 female (F); P=0·78 and 0·39 respectively) were recruited prospectively. H. pylori sero-prevalence was not significantly different between asthmatic and control subjects (P>0·05) Serum H. pylori IgG levels did not correlate with FEV 1% predicted, FVC% predicted or duration of asthma (P>0·05). Similar to the results of previously published sero-epidemiological studies, there was a weak correlation between serum H. pylori IgG with increasing age (r=0·43, P=0·004 Despite the sero-epidemiological association of H. pylori infection with many inflammatory conditions, our data showed no such association for middle age asthmatic patients with mild intermittent asthma in our locality.
Persistent Identifierhttp://hdl.handle.net/10722/162390
ISSN
2023 Impact Factor: 3.5
2023 SCImago Journal Rankings: 1.180
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorTsang, KWen_US
dc.contributor.authorLam, WKen_US
dc.contributor.authorChan, KNen_US
dc.contributor.authorHu, Wen_US
dc.contributor.authorWu, Aen_US
dc.contributor.authorKwok, Een_US
dc.contributor.authorZheng, Len_US
dc.contributor.authorWong, BCYen_US
dc.contributor.authorLam, SKen_US
dc.date.accessioned2012-09-05T05:19:33Z-
dc.date.available2012-09-05T05:19:33Z-
dc.date.issued2000en_US
dc.identifier.citationRespiratory Medicine, 2000, v. 94 n. 8, p. 756-759en_US
dc.identifier.issn0954-6111en_US
dc.identifier.urihttp://hdl.handle.net/10722/162390-
dc.description.abstractAsthma is a very common respiratory disease which is characterized by the presence of cytokine-mediated airway inflammation leading to smooth muscle contraction, oedema and progressive airway damage in some cases. In light of our recent finding of an increased sero-prevalence of Helicobacter pylori in bronchiectasis, we have determined serum levels of H. pylori-specific IgG in asthmatic and control subjects. Altogether 90 consecutive asthmatic [mean age±SD 42·6±16 years and 52 female (F)] and 97 healthy control subjects (mean age ±SD 43·2 ± 13·3 years and 51 female (F); P=0·78 and 0·39 respectively) were recruited prospectively. H. pylori sero-prevalence was not significantly different between asthmatic and control subjects (P>0·05) Serum H. pylori IgG levels did not correlate with FEV 1% predicted, FVC% predicted or duration of asthma (P>0·05). Similar to the results of previously published sero-epidemiological studies, there was a weak correlation between serum H. pylori IgG with increasing age (r=0·43, P=0·004 Despite the sero-epidemiological association of H. pylori infection with many inflammatory conditions, our data showed no such association for middle age asthmatic patients with mild intermittent asthma in our locality.en_US
dc.languageengen_US
dc.publisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/rmeden_US
dc.relation.ispartofRespiratory Medicineen_US
dc.subjectAsthma-
dc.subjectHelicobacter pylori-
dc.subjectInflammation-
dc.subjectSero-revalence-
dc.subject.meshAdulten_US
dc.subject.meshAntibodies, Bacterial - Blooden_US
dc.subject.meshAsthma - Microbiology - Physiopathologyen_US
dc.subject.meshEnzyme-Linked Immunosorbent Assayen_US
dc.subject.meshFemaleen_US
dc.subject.meshForced Expiratory Volume - Physiologyen_US
dc.subject.meshHelicobacter Pylori - Immunologyen_US
dc.subject.meshHumansen_US
dc.subject.meshImmunoglobulin G - Blooden_US
dc.subject.meshMaleen_US
dc.subject.meshProspective Studiesen_US
dc.subject.meshSeroepidemiologic Studiesen_US
dc.subject.meshVital Capacity - Physiologyen_US
dc.titleHelicobacter pylori sero-prevalence in asthmaen_US
dc.typeArticleen_US
dc.identifier.emailWong, BCY:bcywong@hku.hken_US
dc.identifier.authorityWong, BCY=rp00429en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1053/rmed.2000.0817en_US
dc.identifier.pmid10955750-
dc.identifier.scopuseid_2-s2.0-0033867696en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0033867696&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume94en_US
dc.identifier.issue8en_US
dc.identifier.spage756en_US
dc.identifier.epage759en_US
dc.identifier.isiWOS:000088764800004-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.scopusauthoridTsang, KW=7201555024en_US
dc.identifier.scopusauthoridLam, WK=7203021937en_US
dc.identifier.scopusauthoridChan, KN=15737866400en_US
dc.identifier.scopusauthoridHu, W=25932937100en_US
dc.identifier.scopusauthoridWu, A=7402998620en_US
dc.identifier.scopusauthoridKwok, E=7005571440en_US
dc.identifier.scopusauthoridZheng, L=7403404086en_US
dc.identifier.scopusauthoridWong, BCY=7402023340en_US
dc.identifier.scopusauthoridLam, SK=7402279473en_US
dc.identifier.issnl0954-6111-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats